Company	Price	Valuation					Profitability					Cash & leverage					Quality				Rating
		P/E	P/B	P/S	EV / EBITDA	DCF upside	Gross margin	Operating margin	Net margin	ROE	ROIC	FCF yield	Debt / equity	Net debt / EBITDA	Interest coverage	Current ratio	Dividend yield	Piotroski (0-9)	Altman Z	Rating score (1-5)
WGSthis companyGeneDx Holdings Corp.	$65.90	-178.16×	11.35×	8.18×	534.93×	-360.2%	69.7%	-2.8%	-4.9%	-6.8%	-2.5%	0.4%	0.49×	7.09×	-4.65×	2.46×	0.0%	3	1.28	1	D+
AIDX20/20 Biolabs Inc.	$0.19	-39.75×	-7,761.78×	72.96×	-116.21×	-55051.6%	29.6%	-162.9%	-182.8%	19447.7%	-1.9%	-1286.5%	-66,789.49×	-73.63×	-21.32×	0.6×	0.0%	4	-9.63	2	C
BLLNBillionToOne, Inc.	$113.55	1,284.77×	7.81×	12.29×	170.11×	1225.6%	68.3%	5.3%	2.4%	1.6%	2.6%	0.4%	0.23×	-19.59×	168.66×	11.69×	0.0%	7	17.31	3	B-
CSTLCastle Biosciences, Inc.	$32.57	-46.87×	2.39×	3.28×	92.37×	-640.8%	79.4%	-12.4%	-7.0%	-5.1%	-6.8%	2.5%	0.08×	-7.04×	-497.79×	5.26×	0.0%	3	7.56	2	B-
FLGTFulgent Genetics, Inc.	$24.25	-13.34×	0.73×	2.51×	-16.71×	-77.3%	40.6%	-28.2%	-18.8%	-5.4%	-7.1%	-15.4%	0.01×	0.93×	-1,214.61×	6.48×	0.0%	5	4.47	3	B-
IMDXInsight Molecular Diagnostics Inc.	$2.67	-4.55×	-7.26×	56.37×	-4.6×	-189.3%	4.7%	-754.1%	-1238.5%	159.6%	-197.4%	-11.1%	-0.11×	0.17×	-280.53×	1.27×	0.0%	1	-23.74	2	C
Peer median	—	-13.34×	0.73×	12.29×	-4.6×	-189.3%	40.6%	-28.2%	-18.8%	1.6%	-6.8%	-11.1%	0.01×	-7.04×	-280.53×	5.26×	0.0%	4	4.47	2	—